Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nutrients|July 12, 2025
Nutritional Management of Functioning GEP-NENsMaribel Del Olmo-García, Lorena Hernandez-Rienda, Maria Argente Pla, et al.
Endocrine Oncology (Bristol, England)|December 8, 2025
Exploring the carcinoid crisis: insights from a cancer-specific centreMaribel Del Olmo-García, Grace Kong, HuiLi Wong, et al.
Endocrine|October 26, 2010
Metabolic acidosis as a complication of intravenous dextrose administration in a patient with insulinomaAgustín Ramos-Prol, Maribel del Olmo-García, Antonia Pérez-Lázaro, et al.
Endocrine-Related Cancer|April 11, 2025
Spanish consensus on the diagnosis and management of adrenocortical carcinomaMarta Araujo-Castro, Cristina Álvarez-Escola, Ana Casteràs, et al.
Frontiers in Nutrition|June 11, 2026
A prediction tool for malnutrition and sarcopenia in patients with gastroenteropancreatic neuroendocrine neoplasms: results from NUTRIGETNE (GETNE-S2109) studyMaria Argente-Pla, Miguel Antonio Sampedro-Nuñez, Rocio Garcia-Carbonero, et al.
The Oncologist|February 25, 2025
Nutritional status and quality of life of patients with advanced gastroenteropancreatic neuroendocrine neoplasms in Spain: the NUTRIGETNE (GETNE-S2109) studyMaribel Del Olmo-García, Lorena Hernandez-Rienda, Rocio Garcia-Carbonero, et al.
Lancet (London, England)|July 2, 2026
[177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trialThomas Walter, Henning Jann, Catherine Ansquer, et al.
BMC Cancer|April 4, 2025
A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)Jaume Capdevila, Virginia Pubul, Urbano Anido, et al.
Pageof 1